文献速递传染病防控与疫情报告免疫规划

优化脊灰疫情应对操作可量化获益:基于模型的分析

Quantifying the benefits of improved operations for polio outbreak response: A model-based analysis.
PubMed 文献 · Vaccine · 2026-05-30

该研究扩展脊灰病毒传播模型,模拟尼日利亚2024–2028年cVDPV2传播,比较优先分配nOPV2给接种不足者与增加接种轮次两种操作变化。结果显示,仅理想化分配联合每轮5剂次才实现传播阻断;基于OPV2接种史的优先分配可缩小疫情并减少nOPV2用量,而基于IPV接种史的优先分配效果更差。

要点

  • 基于OPV2接种史优先分配nOPV2可缩小疫情并减少疫苗用量
  • 仅理想化分配联合每轮5剂次实现了传播阻断
  • 仅靠反应性疫情应对可能不足以在高风险地区阻断cVDPV2

核心结论

  • 基于OPV2接种史优先分配接种不足者及增加接种轮次均可减少cVDPV2传播。
  • 仅靠反应性疫情应对可能不足以在尼日利亚等高危地区阻断cVDPV2疫情。

研究设计与样本

  • 研究改编并扩展脊灰病毒传播模型,模拟尼日利亚2024–2028年cVDPV2传播。
  • 情景按疫苗分配策略(基线、基于OPV2或IPV接种史优先、理想化优先)和每轮接种剂次(3至5轮)变化。

主要发现

  • 仅理想化分配联合每轮5剂次的情景实现传播阻断,其余情景cVDPV2传播持续至2028年底。
  • 相同接种轮次下,基于OPV2接种史优先分配较基线分配疫情规模更小且nOPV2用量更少。
  • 基于IPV接种史优先分配导致疫情规模更大且nOPV2用量更高。

临床怎么用

  • 疫情应对中可优先识别并分配给OPV2接种不足者以提升nOPV2使用效率。
  • 在条件允许时增加每轮疫情应对的接种轮次以增强阻断效果。

局限性

  • 模型模拟结果外推至其他地区需谨慎。
  • 研究未评估常规免疫等项目中扩大nOPV2使用的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Novel type 2-containing oral poliovirus vaccine (OPV2) was introduced in 2021, and over two billion doses have since been used globally for outbreak response. Despite its reduced risk of virus reversion, stopping circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks remains challenging in some countries, highlighting the need to improve outbreak response operations. This study adapted and extended a poliovirus transmission model to evaluate two operational changes in outbreak response: prioritizing under-vaccinated individuals to receive novel OPV2 (nOPV2) and increasing the number of vaccination rounds. METHODS: We simulated cVDPV2 transmission in Nigeria from 2024 to 2028 under multiple outbreak response scenarios. These scenarios varied by vaccine allocation strategy: (1) baseline allocation where all target individual had equal chance of receiving nOPV2; (2) priority allocation where under-vaccinated individuals were prioritized based on their vaccination histories of OPV2 doses received through outbreak response or of inactivated poliovirus vaccine (IPV) doses received through routine immunization; (3) idealized allocation where individuals with the lowest immunity were prioritized. Scenarios also varied in the number of vaccination rounds (3 to 5 rounds per outbreak response). Outcome measures included outbreak size (cumulative cVDPV2 paralytic case counts), time to transmission interruption, and total nOPV2 doses used. RESULTS: Transmission interruption was only achieved under the idealized allocation with five vaccination rounds per response. In all other scenarios, cVDPV2 transmission continued through the end of 2028. Compared with baseline allocation, priority allocation based on OPV2 vaccination history resulted in smaller outbreak sizes with fewer nOPV2 doses for the same number of vaccination rounds, whereas priority allocation based on IPV vaccination history led to larger outbreak sizes and higher nOPV2 use. CONCLUSIONS: Both prioritizing under-vaccinated individuals based on OPV2 vaccination history and increasing the number of vaccination rounds reduce cVDPV2 transmission. However, reactive outbreak response alone may be insufficient to stop cVDPV2 outbreaks in high-risk settings such as Nigeria, as the required operational improvements may exceed programmatic capacity. Future work should evaluate the role of expanded nOPV2 use in other vaccination programs, such as routine immunization, to support cVDPV2 elimination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Sun Y, Keskinocak P, Kovacs SD, et al. Quantifying the benefits of improved operations for polio outbreak response: A model-based analysis. Vaccine. 2026. PMID: 42217520. doi:10.1016/j.vaccine.2026.128689

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。